Affiliation:
1. EuroEspes Biomedical Research Center, International Center of Neuroscience and Genomic Medicine, 15165 Bergondo, Corunna, Spain
Abstract
Neurodegenerative disorders (NDDs) are major health issues in Western countries. Despite significant efforts, no effective therapeutics for NDDs exist. Several drugs that target epigenetic mechanisms (epidrugs) have been recently developed for the treatment of NDDs, and several of these are currently being tested in clinical trials. Furthermore, various bioproducts have shown important biological effects for the potential prevention and treatment of these disorders. Here, we review the use of natural products as epidrugs to treat NDDs in order to explore the epigenetic effects and benefits of functional foods and natural bioproducts on neurodegeneration.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference215 articles.
1. Alzheimer’s Association (2020). 2020 Alzheimer’s disease facts and figures. Alzheimers Dement., 16, 391–460.
2. GDB (2022). 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study. Lancet Public Health, 7, e105–e125.
3. Can cloud-based tools accelerate Alzheimer’s disease drug discovery?;Cacabelos;Expert Opin. Drug. Discov.,2016
4. Pharmacogenomics of Alzheimer’s and Parkinson’s Diseases;Cacabelos;Neurosci. Lett.,2018
5. Molecular genetics of Alzheimer’s disease and ageing;Cacabelos;Methods Find Exp. Clin. Pharm.,2005
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献